Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.7600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots28.7500/ 1
- Ask / Lots29.0000/ 1
- Open / Previous Close0.0000 / 28.7600
- Day Range---
- 52 Week Range
- Volume13
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 25339 | 28.29 |
| 09:34 ET | 121868 | 28.25 |
| 09:36 ET | 67778 | 28.345 |
| 09:38 ET | 14321 | 28.52 |
| 09:39 ET | 6514 | 28.535 |
| 09:41 ET | 10988 | 28.58 |
| 09:43 ET | 9787 | 28.56 |
| 09:45 ET | 84356 | 28.46 |
| 09:48 ET | 21023 | 28.425 |
| 09:50 ET | 19310 | 28.455 |
| 09:52 ET | 18354 | 28.425 |
| 09:54 ET | 11342 | 28.47 |
| 09:56 ET | 13532 | 28.5025 |
| 09:57 ET | 34296 | 28.565 |
| 09:59 ET | 7636 | 28.58 |
| 10:01 ET | 80652 | 28.595 |
| 10:03 ET | 10178 | 28.615 |
| 10:06 ET | 19335 | 28.645 |
| 10:08 ET | 18735 | 28.675 |
| 10:10 ET | 17159 | 28.685 |
| 10:12 ET | 16571 | 28.755 |
| 10:14 ET | 12276 | 28.64 |
| 10:15 ET | 7540 | 28.55 |
| 10:17 ET | 8659 | 28.45 |
| 10:19 ET | 5930 | 28.42 |
| 10:21 ET | 8461 | 28.435 |
| 10:24 ET | 4641 | 28.48 |
| 10:26 ET | 9470 | 28.425 |
| 10:28 ET | 5023 | 28.46 |
| 10:30 ET | 8238 | 28.475 |
| 10:32 ET | 4372 | 28.49 |
| 10:33 ET | 11890 | 28.565 |
| 10:35 ET | 6893 | 28.585 |
| 10:37 ET | 15099 | 28.525 |
| 10:39 ET | 10332 | 28.555 |
| 10:42 ET | 9809 | 28.585 |
| 10:44 ET | 25886 | 28.55 |
| 10:46 ET | 10633 | 28.565 |
| 10:48 ET | 8845 | 28.565 |
| 10:50 ET | 12440 | 28.61 |
| 10:51 ET | 25759 | 28.585 |
| 10:53 ET | 8432 | 28.615 |
| 10:55 ET | 6977 | 28.65 |
| 10:57 ET | 8727 | 28.615 |
| 11:00 ET | 10104 | 28.635 |
| 11:02 ET | 19323 | 28.62 |
| 11:04 ET | 5434 | 28.635 |
| 11:06 ET | 8554 | 28.635 |
| 11:08 ET | 5943 | 28.625 |
| 11:09 ET | 8603 | 28.635 |
| 11:11 ET | 8772 | 28.63 |
| 11:13 ET | 4774 | 28.635 |
| 11:15 ET | 24574 | 28.615 |
| 11:18 ET | 8516 | 28.605 |
| 11:20 ET | 68991 | 28.54 |
| 11:22 ET | 11912 | 28.625 |
| 11:24 ET | 4286 | 28.615 |
| 11:26 ET | 172054 | 28.545 |
| 11:27 ET | 2696 | 28.55 |
| 11:29 ET | 5719 | 28.53 |
| 11:31 ET | 6560 | 28.525 |
| 11:33 ET | 7454 | 28.54 |
| 11:36 ET | 13348 | 28.565 |
| 11:38 ET | 2640 | 28.605 |
| 11:40 ET | 6752 | 28.63 |
| 11:42 ET | 2381 | 28.665 |
| 11:44 ET | 32000 | 28.685 |
| 11:45 ET | 6855 | 28.705 |
| 11:47 ET | 7749 | 28.735 |
| 11:49 ET | 4860 | 28.7484 |
| 11:51 ET | 9773 | 28.79 |
| 11:54 ET | 6386 | 28.715 |
| 11:56 ET | 8650 | 28.72 |
| 11:58 ET | 9594 | 28.7 |
| 12:00 ET | 10030 | 28.73 |
| 12:02 ET | 4300 | 28.725 |
| 12:03 ET | 10864 | 28.755 |
| 12:05 ET | 29453 | 28.775 |
| 12:07 ET | 4979 | 28.76 |
| 12:09 ET | 4960 | 28.76 |
| 12:12 ET | 5863 | 28.7701 |
| 12:14 ET | 14176 | 28.785 |
| 12:16 ET | 3200 | 28.785 |
| 12:18 ET | 6205 | 28.8 |
| 12:20 ET | 15817 | 28.82 |
| 12:21 ET | 19065 | 28.815 |
| 12:23 ET | 6049 | 28.84 |
| 12:25 ET | 3712 | 28.845 |
| 12:27 ET | 903 | 28.845 |
| 12:30 ET | 4940 | 28.845 |
| 12:32 ET | 2638 | 28.825 |
| 12:34 ET | 3672 | 28.83 |
| 12:36 ET | 15109 | 28.835 |
| 12:38 ET | 3969 | 28.795 |
| 12:39 ET | 9091 | 28.845 |
| 12:41 ET | 3255 | 28.8225 |
| 12:43 ET | 9035 | 28.855 |
| 12:45 ET | 4616 | 28.855 |
| 12:48 ET | 5298 | 28.865 |
| 12:50 ET | 5973 | 28.885 |
| 12:52 ET | 25541 | 28.815 |
| 12:54 ET | 7265 | 28.819 |
| 12:56 ET | 8148 | 28.815 |
| 12:57 ET | 10987 | 28.86 |
| 12:59 ET | 9248 | 28.89 |
| 01:01 ET | 4873 | 28.875 |
| 01:03 ET | 2723 | 28.86 |
| 01:06 ET | 7446 | 28.87 |
| 01:08 ET | 6754 | 28.895 |
| 01:10 ET | 5252 | 28.935 |
| 01:12 ET | 12927 | 28.95 |
| 01:14 ET | 6215 | 28.98 |
| 01:15 ET | 10935 | 28.975 |
| 01:17 ET | 6519 | 28.97 |
| 01:19 ET | 8573 | 28.975 |
| 01:21 ET | 3850 | 28.975 |
| 01:24 ET | 20095 | 28.98 |
| 01:26 ET | 42199 | 28.94 |
| 01:28 ET | 28462 | 28.87 |
| 01:30 ET | 24418 | 28.885 |
| 01:32 ET | 10395 | 28.93 |
| 01:33 ET | 2567 | 28.9 |
| 01:35 ET | 4439 | 28.895 |
| 01:37 ET | 31905 | 28.815 |
| 01:39 ET | 9483 | 28.795 |
| 01:42 ET | 4447 | 28.765 |
| 01:44 ET | 4501 | 28.785 |
| 01:46 ET | 1703 | 28.785 |
| 01:48 ET | 7852 | 28.765 |
| 01:50 ET | 2912 | 28.7782 |
| 01:51 ET | 1754 | 28.78 |
| 01:53 ET | 2816 | 28.79 |
| 01:55 ET | 12294 | 28.805 |
| 01:57 ET | 4628 | 28.75 |
| 02:00 ET | 4263 | 28.77 |
| 02:02 ET | 46817 | 28.805 |
| 02:04 ET | 7702 | 28.85 |
| 02:06 ET | 28026 | 28.8 |
| 02:08 ET | 11589 | 28.8 |
| 02:09 ET | 8799 | 28.8 |
| 02:11 ET | 7259 | 28.785 |
| 02:13 ET | 7805 | 28.77 |
| 02:15 ET | 1244 | 28.78 |
| 02:18 ET | 13210 | 28.765 |
| 02:20 ET | 36770 | 28.765 |
| 02:22 ET | 5376 | 28.77 |
| 02:24 ET | 7298 | 28.755 |
| 02:26 ET | 1741 | 28.78 |
| 02:27 ET | 4511 | 28.8 |
| 02:29 ET | 2452 | 28.8 |
| 02:31 ET | 6238 | 28.79 |
| 02:33 ET | 3258 | 28.8 |
| 02:36 ET | 11648 | 28.8 |
| 02:38 ET | 9030 | 28.8 |
| 02:40 ET | 4222 | 28.79 |
| 02:42 ET | 12400 | 28.8 |
| 02:44 ET | 7726 | 28.79 |
| 02:45 ET | 5200 | 28.78 |
| 02:47 ET | 5307 | 28.81 |
| 02:49 ET | 11726 | 28.825 |
| 02:51 ET | 11278 | 28.85 |
| 02:54 ET | 15774 | 28.88 |
| 02:56 ET | 10497 | 28.89 |
| 02:58 ET | 9938 | 28.8825 |
| 03:00 ET | 36826 | 28.845 |
| 03:02 ET | 29443 | 28.845 |
| 03:03 ET | 22636 | 28.835 |
| 03:05 ET | 6817 | 28.845 |
| 03:07 ET | 12100 | 28.815 |
| 03:09 ET | 18038 | 28.735 |
| 03:12 ET | 7642 | 28.745 |
| 03:14 ET | 14353 | 28.725 |
| 03:16 ET | 13333 | 28.695 |
| 03:18 ET | 19974 | 28.715 |
| 03:20 ET | 18974 | 28.735 |
| 03:21 ET | 11353 | 28.715 |
| 03:23 ET | 18720 | 28.675 |
| 03:25 ET | 12895 | 28.645 |
| 03:27 ET | 18666 | 28.685 |
| 03:30 ET | 13080 | 28.65 |
| 03:32 ET | 11087 | 28.645 |
| 03:34 ET | 14135 | 28.635 |
| 03:36 ET | 12634 | 28.63 |
| 03:38 ET | 40759 | 28.665 |
| 03:39 ET | 19502 | 28.725 |
| 03:41 ET | 22393 | 28.74 |
| 03:43 ET | 16159 | 28.73 |
| 03:45 ET | 23862 | 28.685 |
| 03:48 ET | 24185 | 28.685 |
| 03:50 ET | 22293 | 28.7 |
| 03:52 ET | 37280 | 28.69 |
| 03:54 ET | 38813 | 28.75 |
| 03:56 ET | 68189 | 28.76 |
| 03:57 ET | 48003 | 28.745 |
| 03:59 ET | 60547 | 28.76 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 17.2B | 11.3x | +1.83% |
Amneal Pharmaceuticals Inc | 1.9B | -19.9x | --- |
Catalent Inc | 10.2B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 22.5x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -43.4x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.2B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.92% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.3x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 10.1x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
